5-hydroxy-6-methoxyindole: from supernatant of melanoma cell culture
ID Source | ID |
---|---|
PubMed CID | 164957 |
SCHEMBL ID | 1959555 |
MeSH ID | M0115327 |
Synonym |
---|
6-methoxy-1h-indol-5-ol |
5h6mi |
inchi=1/c9h9no2/c1-12-9-5-7-6(2-3-10-7)4-8(9)11/h2-5,10-11h,1h |
2380-83-8 |
AKOS006273019 |
5-hydroxy-6-methoxyindole |
1h-indol-5-ol, 6-methoxy- |
SCHEMBL1959555 |
WZARGPVIAOAKMH-UHFFFAOYSA-N |
5-hydroxy-6-methoxylindole |
DTXSID60178496 |
FT-0774818 |
EN300-6406528 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |